Related Experiment Video
Updated: Jul 26, 2026

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
New Federal Regulations for Improving Quality in Opioid Treatment Programs
Luc R Pelletier1, Jeffrey A Hoffman
1Luc R. Pelletier is a healthcare consultant in Washington, DC, and is Editor-in-Chief of JHQ. When he wrote this article, he was project director for the Performance Measurement for Treatment Improvement (PMTI) project at Danya International, Inc., in Silver Spring, MD. In October 2001, Pelletier was the recipient of the American Psychiatric Nurses Association Excellence in Leadership Award–Advanced.
Federal regulations for opioid treatment programs (OTPs) have shifted oversight from the FDA to SAMHSA. New accreditation standards are being developed, and preliminary findings indicate OTPs can meet them.
Area of Science:
- Public Health
- Health Policy
- Substance Abuse Treatment
Background:
- Federal methadone treatment regulations, largely unchanged since 1972, are being updated.
- Oversight responsibility for opioid treatment programs (OTPs) is transitioning from the FDA to SAMHSA.
- New federal regulations necessitate updated standards for OTPs.
Purpose of the Study:
- To review the necessity for recent changes in methadone treatment oversight.
- To examine the historical context of methadone treatment regulation.
- To detail the development of new accreditation requirements for OTPs.
Main Methods:
- Review of historical federal regulations and recent legislative changes.
- Analysis of the development process for new accreditation guidelines by SAMHSA.
- Examination of stakeholder responses to proposed regulatory changes.
- Identification of key performance domains for OTPs.
Main Results:
- Preliminary data suggest that OTPs are capable of meeting the new accreditation standards.
- The shift in oversight aims to modernize and improve the regulation of opioid treatment.
Conclusions:
- The updated regulatory framework, with SAMHSA oversight and accreditation standards, represents a significant change for OTPs.
- Ongoing evaluation of OTP performance against accreditation standards will be crucial.
- These changes are expected to enhance the quality and consistency of methadone treatment nationwide.
Related Concept Videos
Drug Regulation
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Control Governance: Regulatory Bodies and Their Impact

